These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Rasburicase causing severe oxidative hemolysis and methemoglobinemia in a patient with previously unrecognized glucose-6-phosphate dehydrogenase deficiency. Cheah CY; Lew TE; Seymour JF; Burbury K Acta Haematol; 2013; 130(4):254-9. PubMed ID: 23860572 [TBL] [Abstract][Full Text] [Related]
5. Rasburicase-Induced Methemoglobinemia in a Patient with Glucose-6- Phosphate Dehydrogenase Deficiency. Khan M; Paul S; Farooq S; Oo TH; Ramshesh P; Jain N Curr Drug Saf; 2017; 12(1):13-18. PubMed ID: 28078984 [TBL] [Abstract][Full Text] [Related]
6. Methemoglobinemia induced by rasburicase in a pediatric patient: a case report and literature review. Ng JS; Edwards EM; Egelund TA J Oncol Pharm Pract; 2012 Dec; 18(4):425-31. PubMed ID: 22190578 [TBL] [Abstract][Full Text] [Related]
7. Brisk clinical response to erythrocytapheresis in a G6PD-deficient patient with rasburicase-induced methemoglobinemia. Cooling L J Clin Apher; 2017 Dec; 32(6):599-600. PubMed ID: 28370399 [No Abstract] [Full Text] [Related]
8. Hemolysis and methemoglobinemia secondary to rasburicase administration. Browning LA; Kruse JA Ann Pharmacother; 2005 Nov; 39(11):1932-5. PubMed ID: 16204390 [TBL] [Abstract][Full Text] [Related]
9. I.V. ascorbic acid for treatment of apparent rasburicase-induced methemoglobinemia in a patient with acute kidney injury and assumed glucose-6-phosphate dehydrogenase deficiency. Reeves DJ; Saum LM; Birhiray R Am J Health Syst Pharm; 2016 May; 73(9):e238-42. PubMed ID: 27099330 [TBL] [Abstract][Full Text] [Related]
10. Testing for Glucose-6-Phosphate Dehydrogenase Deficiency Before Rasburicase Use for Tumor Lysis Syndrome. Lakra R; Grewal US; Ramadas P Am J Ther; 2023 Sep-Oct 01; 30(5):e465-e467. PubMed ID: 37713696 [No Abstract] [Full Text] [Related]
11. Mortality following rasburicase-induced methemoglobinemia. Bucklin MH; Groth CM Ann Pharmacother; 2013 Oct; 47(10):1353-8. PubMed ID: 24259700 [TBL] [Abstract][Full Text] [Related]
12. Rasburicase-induced haemolysis and methemoglobinemia: an ongoing issue. Madanat L; Schoenherr D; Wey E; Gupta R BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33727299 [TBL] [Abstract][Full Text] [Related]
14. Methaemoglobinaemia and haemolysis after rasburicase administration in a patient with G6PD deficiency. Boussaid I; Mondesir J; Chapuis N; Birsen R BMJ Case Rep; 2022 Oct; 15(10):. PubMed ID: 36198433 [No Abstract] [Full Text] [Related]
15. Rasburicase-induced methemoglobinemia in two African-American female patients: an under-recognized and continued problem. Roberts DA; Freed JA Eur J Haematol; 2015 Jan; 94(1):83-5. PubMed ID: 24750455 [TBL] [Abstract][Full Text] [Related]
16. Distinct mechanisms for rasburicase induced hemolytic anemia and methemoglobinemia in tumor lysis syndrome. Lopes da Silva R Int J Clin Pharm; 2011 Jun; 33(3):471-2. PubMed ID: 21519817 [No Abstract] [Full Text] [Related]
17. Rare Case of Transcutaneous Oxygen Desaturation in a Cancer Patient: A Case Report and Diagnostic Approach for a Recurrent Problem. Bachmann KF; Nebiker M; Johner C; Bregy R; Schaller A; Novak U; Jakob SM A A Pract; 2019 Feb; 12(4):96-98. PubMed ID: 30052534 [TBL] [Abstract][Full Text] [Related]
18. Methemoglobinemia secondary to rasburicase in cancer: Non drug-related oxidative stress. Lopes da Silva R J Oncol Pharm Pract; 2016 Jun; 22(3):573-4. PubMed ID: 26223797 [No Abstract] [Full Text] [Related]
19. Rasburicase-induced methemoglobinemia: The eyes do not see what the mind does not know. Ibrahim U; Saqib A; Mohammad F; Atallah JP; Odaimi M J Oncol Pharm Pract; 2018 Jun; 24(4):309-313. PubMed ID: 28345492 [TBL] [Abstract][Full Text] [Related]
20. Report of two cases of rasburicase-induced methemoglobinemia. Kizer N; Martinez E; Powell M Leuk Lymphoma; 2006 Dec; 47(12):2648-50. PubMed ID: 17169811 [No Abstract] [Full Text] [Related] [Next] [New Search]